Company profile · Biotech & medical
Tanvex BioPharma
泰福生技股份有限公司 · 6541
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Tanvex BioPharma provides contract development and manufacturing organization (CDMO) services for biologics and engages in the development, manufacturing, and sales of biosimilars.[1]
The company offers full-process CDMO services including cell line development, process development, analytical method validation, and cGMP manufacturing for clinical trials and mass production.[1]
Its operations are supported by a Taiwan branch focused on R&D and pilot production services, and a U.S. subsidiary with a cGMP-certified production facility located in San Diego.[1]
The company's biosimilar portfolio includes products such as TX01 for supportive cancer treatment and TX05 for breast cancer.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$53m | +13.7% | +67.0% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$8m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Tanvex BioPharma, Inc. |
|---|---|
| Chinese name | 泰福生技股份有限公司 |
| Stock code | 6541 (TWSE) |
| Industry | Biotech & medical |
| Founded | 08 May 2013 |
| Listed | 26 Oct 2017 |
| Paid-in capital | NT$2.7bn |
| Chairman | 盛保熙 |
| President | 官振儀 |
| Headquarters | 6F, No. 12-2, Sec. 2, Shengyi Rd., Zhubei City Hsinchu County, Taiwan (R.O.C.) |
| Website | https://www.tanvex.com |
| Official business description | 生物相似藥及新藥之研發、製造及銷售。 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list